Mark W. SURBER,Keith A. BOSTIAN,Michael N. DUDLEY,Olga RODNY,David C. GRIFFITH
申请号：
US16250520
公开号：
US20190381057A1
申请日:
2019.01.17
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
